SIMULECT

Product Overview

About SIMULECT

SIMULECT is a prescription medicine used to prevent rejection in patients who have received a kidney transplant. It contains the active ingredient basiliximab, a monoclonal antibody that targets the interleukin-2 receptor alpha subunit.

Key Benefits & Uses

• Prevents rejection in kidney transplant patients
• Reduces the risk of acute rejection episodes
• May be used in combination with other immunosuppressive medications

Active Ingredient & Action

Basiliximab works by binding to the interleukin-2 receptor alpha subunit, which is involved in the activation and proliferation of T-cells. By blocking this receptor, basiliximab reduces the immune response and helps to prevent rejection in transplant patients.

Important Notes

SIMULECT should only be used under the guidance of a healthcare professional. It is essential to follow the recommended dosing schedule and to report any adverse reactions or concerns to your doctor. As with any medication, there may be potential side effects, including infusion reactions, headache, and nausea.